SCHEMBL6480221

SCHEMBL6480221

Cc1c(CF)nn2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 2/20 0.36
PDE5A O76074 4/20 0.36
PDE4B Q07343 3/20 0.36
ALDH1A1 P00352 3/20 0.36
PDE3A Q14432 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
PDE4A P27815 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
PDE3B Q13370 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489306 0.84 DRD2 (0.39) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL22168371 0.82 EGFR (0.38) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL16425978 0.82 MIF (0.39) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL23587418 0.81 LCK (0.41) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL6480217 0.79 EGFR (0.35) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL6490727 0.75 PDE5A (0.44) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL14809647 0.72 PDE5A (0.41) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL19700226 0.72 EGFR (0.49) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL6629043 0.71 ALDH1A1 (0.36) MIFPDE5APDE4BALDH1A1PDE3A
SCHEMBL18560573 0.70 MEN1 (0.48) ALDH1A1MEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed